USB
42
2
VRSK
56
16
AKAM
62
3
F
43
3
AMP
63
3
CVS
52
3
CMS
70
2
NTRS
44
5
AEP
66
2
EBAY
50
-2
NFLX
59
2
PRGO
50
3
URBN
30
3
CMA
58
2
ILMN
38
2
FFIV
67
3
FSLR
64
-6
GE
82
5
HSY
40
2
D
63
2
USB
42
2
VRSK
56
16
AKAM
62
3
F
43
3
AMP
63
3
CVS
52
3
CMS
70
2
NTRS
44
5
AEP
66
2
EBAY
50
-2
NFLX
59
2
PRGO
50
3
URBN
30
3
CMA
58
2
ILMN
38
2
FFIV
67
3
FSLR
64
-6
GE
82
5
HSY
40
2
D
63
2
Financhill
Back

Bio-Path Holdings 10K Form

Sell
29

BPTH
Bio-Path Holdings

Last Price:
1.03
Seasonality Move:
9.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-14 10Q BPTH/Bio-Path Holdings Quarterly
2023-11-14 10Q BPTH/Bio-Path Holdings Quarterly
2023-08-14 10Q BPTH/Bio-Path Holdings Quarterly
2023-05-11 10Q BPTH/Bio-Path Holdings Quarterly
2022-11-14 10Q BPTH/Bio-Path Holdings Quarterly
2022-08-15 10Q BPTH/Bio-Path Holdings Quarterly

Receive BPTH News And Ratings

See the #1 stock for the next 7 days that we like better than BPTH

BPTH Financial Statistics

Sales & Book Value

Annual Sales: $37K
Cash Flow: $-3.23M
Price / Cash Flow: 0
Annual Sales: $0.57
Price / Book: 2.02

Profitability

EPS (TTM): -16.67000
Net Income (TTM): $-11.6M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Bio-Path Holdings Earnings Forecast

Key Bio-Path Holdings Financial Ratios

  • The Gross Profit Margin over the past 13 years for BPTH is 0.00%.
  • The Selling, General & Administrative Expenses for BPTH have been equal to 9,521.62% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 20 years have been positive in 8 years.

Bio-Path Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BPTH
CUSIP: 09057N
Website: biopathholdings.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BPTH Technical Analysis vs Fundamental Analysis

Sell
29
Bio-Path Holdings (BPTH) is a Sell

Is Bio-Path Holdings a Buy or a Sell?

  • Bio-Path Holdings stock is rated a Sell
    The current Bio-Path Holdings [BPTH] share price is $1.02. The Score for BPTH is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.